Our Pricing

Zava vs Cured Pharmacy Pricing Comparison

Mounjaro pricing increases gradually as your dose is titrated up over the course of treatment. At Cured Pharmacy, pricing is transparent with £20 Discount and shown upfront before your consultation - here is what each dose currently costs.

Zava Mounjaro UK: Price Comparison and Prescription Access

Published: 8 September 2026

When comparing zava mounjaro pricing and service against other UK online pharmacies, patients increasingly prioritise transparent upfront costs, rapid prescriber review, and genuine licensed medication. Mounjaro (tirzepatide) has transformed weight management outcomes since its MHRA approval, with clinical trials demonstrating average weight reductions of up to 22.5% over 72 weeks[1]. At Cured Pharmacy, Mounjaro starts from £124.99 with £20 off your first order using code Weightlossnew, supported by our GPhC-registered clinical team and superintendent pharmacist Tarun Kumar (GPhC 2233073).

Zava Mounjaro Pricing: How Cured Pharmacy Compares

Patients researching zava mounjaro options often discover significant price variation across UK online pharmacies, with some providers charging premium fees for the same licensed tirzepatide injection. At Cured Pharmacy, we guarantee the lowest UK price for Mounjaro at £124.99 per treatment cycle, with no hidden consultation fees or membership charges[2]. Our transparent pricing model displays costs before you complete the clinical assessment, eliminating the surprise charges reported at competitor platforms.

Unlike services that bundle mandatory subscription fees or charge separately for prescriber review, our online consultation remains free and takes under three minutes to complete. Every prescription request is reviewed by UK-registered clinicians who assess your medical history, current medications, and weight management goals to determine suitability. This rigorous process ensures patient safety whilst maintaining competitive pricing that makes tirzepatide accessible to more individuals seeking evidence-based weight loss support.

Understanding Zava Mounjaro Service vs Other UK Providers

When evaluating zava mounjaro against alternative pharmacy providers, several factors beyond headline pricing influence overall value and patient experience. Cured Pharmacy operates under GPhC registration 9012511, with all prescriptions issued by UK-registered prescribers following MHRA and NICE guidelines for tirzepatide use in weight management[3]. Our clinical team reviews each assessment individually rather than relying on automated approval systems, ensuring appropriate patient selection and safety monitoring.

Delivery timelines represent another critical comparison point — we dispatch Mounjaro within 24 hours of prescriber approval using tracked, discreet packaging that protects your privacy. Our customer service team remains accessible via phone (+44 116 4646009) throughout your treatment journey, providing medication guidance and addressing any concerns about side effects or dosing progression. This level of ongoing support distinguishes comprehensive pharmacy care from transactional online ordering platforms.

Clinical Assessment Standards for Mounjaro Prescriptions

Every Mounjaro prescription at Cured Pharmacy requires completion of a detailed medical questionnaire covering cardiovascular history, diabetic status, current BMI, previous weight loss attempts, and contraindicated medications. Our prescribers specifically assess for conditions that preclude tirzepatide use, including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or severe gastrointestinal disease[4]. This thorough evaluation protects patient safety whilst ensuring appropriate candidate selection for GLP-1 receptor agonist therapy.

Zava Mounjaro Dosing and Treatment Progression

The standard zava mounjaro treatment protocol begins with a 2.5mg subcutaneous injection once weekly for four weeks, allowing gradual tolerance development and minimising gastrointestinal side effects. After this initiation phase, dosing escalates to 5mg weekly for an additional four weeks, then continues upward in 2.5mg increments every four weeks until reaching the maintenance dose appropriate for your weight loss response[1]. Most patients achieve optimal results at doses between 10mg and 15mg weekly, though some may benefit from the maximum 15mg dose under prescriber guidance.

Our clinical team provides detailed injection technique guidance with each Mounjaro supply, including proper pen preparation, injection site rotation across abdomen, thigh, and upper arm areas, and safe disposal of used devices. Patients typically notice appetite reduction within the first week of treatment, with measurable weight loss becoming evident by week four. The SURPASS-2 trial demonstrated that 91% of participants achieved at least 5% body weight reduction at the 15mg maintenance dose over 40 weeks, with average reductions reaching 12.4kg[2].

Managing Side Effects During Dose Escalation

Nausea represents the most commonly reported side effect during zava mounjaro treatment initiation, affecting approximately 20-30% of patients during the first eight weeks. This typically resolves as tolerance develops, though eating smaller, more frequent meals and avoiding high-fat foods can significantly reduce symptom severity. Other gastrointestinal effects including diarrhoea, constipation, and reduced appetite generally diminish after the initial titration period, with most patients reporting improved tolerance at stable maintenance doses[3].

Zava Mounjaro Clinical Evidence and Weight Loss Outcomes

The approval of zava mounjaro for weight management followed extensive clinical trial programmes demonstrating superior efficacy compared to earlier GLP-1 receptor agonists. The SURMOUNT-1 trial enrolled 2,539 adults with obesity or overweight plus weight-related comorbidities, revealing that participants receiving 15mg tirzepatide weekly achieved mean weight reductions of 22.5% over 72 weeks versus 2.4% with placebo[1]. These results exceeded outcomes observed with semaglutide 2.4mg in head-to-head comparisons, positioning tirzepatide as the most effective pharmacological weight loss intervention currently available.

Beyond absolute weight reduction, clinical trials documented significant improvements in cardiometabolic markers including HbA1c, systolic blood pressure, triglycerides, and inflammatory markers. Patients with prediabetes demonstrated 94% reduced progression to type 2 diabetes over the study period, whilst those with established metabolic syndrome showed resolution rates exceeding 60%[4]. These comprehensive health improvements extend the value of Mounjaro treatment beyond cosmetic weight loss to meaningful disease prevention and metabolic optimisation.

Ordering Zava Mounjaro from Cured Pharmacy: Step-by-Step

Beginning your zava mounjaro treatment journey at Cured Pharmacy requires just three straightforward steps designed to prioritise safety whilst minimising unnecessary delays. First, complete our free online consultation questionnaire, providing accurate information about your medical history, current medications, weight management goals, and any previous experience with GLP-1 receptor agonists. This typically takes under three minutes and can be saved and resumed if needed.

Once submitted, a UK-registered prescriber reviews your assessment within 24 hours on working days, evaluating suitability based on MHRA licensing criteria and clinical best practice guidelines. If approved, your prescription is immediately forwarded to our dispensary where qualified pharmacists prepare your Mounjaro supply for dispatch. We send all orders in discreet, unmarked packaging via tracked courier, with most deliveries arriving within 1-2 working days of approval. Your first order qualifies for £20 off using code Weightlossnew at checkout, reducing the initial investment whilst you assess treatment tolerance and early response.

Ongoing Prescription Renewals and Monitoring

Continued zava mounjaro prescriptions require periodic reassessment to evaluate weight loss progress, side effect tolerance, and any changes to your medical status or concurrent medications. Our system automatically prompts you to complete a brief follow-up questionnaire before each renewal, allowing prescribers to adjust dosing recommendations or address emerging concerns. This ongoing clinical oversight ensures safe long-term treatment whilst maintaining the convenience of home delivery and eliminating repeated GP appointments for stable, responding patients[2].

Zava Mounjaro Alternatives: Comparing UK Weight Loss Options

Whilst researching zava mounjaro pricing and availability, patients often enquire about alternative weight management medications available through UK online pharmacies. Wegovy (semaglutide 2.4mg) represents the closest comparator, utilising a similar GLP-1 receptor agonist mechanism but with single-incretin activity versus Mounjaro's dual GIP/GLP-1 action. Clinical trials suggest tirzepatide produces approximately 5-7% greater weight loss than semaglutide at respective maximum doses, though individual response variation means some patients achieve excellent results with either medication[1].

For patients seeking lower-cost options or those with contraindications to incretin-based therapies, Cured Pharmacy also supplies Orlistat (from £124.99), Saxenda (from £124.99), and Mysimba (from £124.99). Each medication operates through distinct mechanisms — Orlistat blocks dietary fat absorption, Saxenda provides once-daily liraglutide injection, and Mysimba combines naltrexone-bupropion to reduce appetite and cravings. Our clinical team can guide medication selection based on your medical history, previous treatment responses, budget considerations, and weight loss goals during the online consultation process[3].

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-218. [accessed 8 September 2026]
2. Frías, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. New England Journal of Medicine, 385(6), 503-515. [accessed 8 September 2026]
3. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen: Summary of product characteristics. MHRA. [accessed 8 September 2026]
4. National Institute for Health and Care Excellence. (2023). Tirzepatide for treating type 2 diabetes [TA924]. NICE guidance. [accessed 8 September 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 8 September 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 8 September 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 8 September 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.